David Nelson lab

Researcher David Nelson, PhD, Explores New Cell Strategies for Fragile X Syndrome, FXTAS and FXPOI

May 31, 2016

David Nelson co-discovered the FMR1 mutation which causes Fragile X syndrome and developed key mouse models, enabling global research aimed at finding treatments for the disorder.

Read More »
Fragile X clinical trial combines two available drugs

Double Down: Fragile X Clinical Trial Combines Two Available Drugs

May 16, 2016

FRAXA funded a trial combining lovastatin and minocycline to test whether targeting multiple pathways can improve brain activity and behavior in Fragile X.

Read More »
Jeannie Lee - Fragile X researcher

The X Factor – Turning on X Chromosome Genes to Treat X-linked Disorders

May 9, 2016

Harvard researcher Jeannie T. Lee, MD, PhD, moves closer to turning on select genes on the X chromosome to treat people with X-linked disorders.

Read More »

Can STEP Inhibitors Treat Fragile X Syndrome? Yale Professor Investigates

March 28, 2016

Yale Professor Paul Lombroso, MD, is testing STEP inhibitors to improve cognitive and social behaviors in those affected by Fragile X syndrome.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)